Medivation, Inc.

4 results found.

Breast Cancer Clinical Trial using Enzalutamide; exemestane; Placebo (for enzalutamide)

Medivation, Inc. - Recruiting 18 years or older.
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer That Is Estrogen or Progesterone Receptor-Positive and HER2-Normal.
Enzalutamide; exemestane; Placebo (for enzalutamide)

Prostate Cancer Clinical Trial using Enzalutamide; Abiraterone; Placebo for Enzalutamide; Prednisone

Medivation, Inc. - Recruiting 18 years or older.
- A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study of Continued Enzalutamide Treatment Beyond Progression in Patients With Chemotherapy-Na‹ve Metastatic Castration-Resistant Prostate Cancer.
Enzalutamide; Abiraterone; Placebo for Enzalutamide; Prednisone

Nonmetastatic Castration-Resistant Prostate Cancer Clinical Trial using Enzalutamide; Placebo

Medivation, Inc. - Recruiting 18 years or older.
- A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer.
Enzalutamide; Placebo

Advanced, Androgen Receptor Positive Triple Negative Breast Cance Clinical Trial using Enzalutamide

Medivation, Inc. - Recruiting 18 years or older.
- A Phase 2, Single Arm, Open Label, Multicenter Study of the Clinical Activity and Safety of Enzalutamide in Patients With Advanced, Androgen Receptor Positive, Triple Negative Breast Cancer.
Enzalutamide